Bericht
Transition period for TRIPS implementation for LDCs: Implications for local production of medicines in the East African community
- Sprache
-
Englisch
- Erschienen in
-
Series: Research Paper ; No. 59
- Klassifikation
-
Sozialwissenschaften, Soziologie, Anthropologie
- Thema
-
TRIPS
Immaterialgüterrechte
Arzneimittel
Pharmaindustrie
Entwicklungsländer
Uganda
Tansania
Burundi
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Syam, Nirmalya
- Ereignis
-
Veröffentlichung
- (wer)
-
South Centre
- (wo)
-
Geneva
- (wann)
-
2014
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Bericht
Beteiligte
- Syam, Nirmalya
- South Centre
Entstanden
- 2014
Ähnliche Objekte (12)
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Policy space for domestic public interest measures under TRIPS
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
A review of WTO disputes on TRIPS: Implications for use of flexibilities for public health
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Non-violation and situation complaints under the TRIPS Agreement: Implications for developing countries
Guidelines on patentability and access to medicines
IP rights under investment agreements: The TRIPS-plus implications for enforcement and protection of public interest
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Policy space for domestic public interest measures under TRIPS
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
A review of WTO disputes on TRIPS: Implications for use of flexibilities for public health
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Non-violation and situation complaints under the TRIPS Agreement: Implications for developing countries
Guidelines on patentability and access to medicines
IP rights under investment agreements: The TRIPS-plus implications for enforcement and protection of public interest
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Policy space for domestic public interest measures under TRIPS
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
A review of WTO disputes on TRIPS: Implications for use of flexibilities for public health
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
Non-violation and situation complaints under the TRIPS Agreement: Implications for developing countries
Guidelines on patentability and access to medicines
IP rights under investment agreements: The TRIPS-plus implications for enforcement and protection of public interest
The international debate on generic medicines of biological origin